Definitive Contract 75D30123C18018

Award Date 9/22/23
Potential Completion Date 9/24/28
Potential Value $1.2M
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marshfield, WI, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, to enhance the serum repository for Lyme disease. The contract has a ceiling value of $237,421.00 and a completion date of September 24, 2022. Marshfield Clinic has a long history of partnering with the CDC and other federal agencies on public health initiatives, including vaccine safety monitoring and COVID-19 research. This...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, for a project titled "USING ELECTRONIC HEALTH RECORDS TO IDENTIFY AND DESCRIBE". The contract has a ceiling value of $1,029,344.00 and a period of performance ending on September 27, 2027. It is a firm fixed price contract and was not set aside for any particular business type. Marshfield Clinic, Inc. is a subsidiary of...
Marshfield Clinic, Inc. was awarded a $1,725,838 firm fixed price definitive contract from the Centers for Disease Control and Prevention (CDC) to support Topic 9 under the Fiscal Year 2021 Broad Agency Announcement. As the prime contractor, Marshfield Clinic will provide services related to the specified topic in Marshfield, Wisconsin through September 30, 2022. No set-aside designation was applied to this contract. Marshfield Clinic is a non-profit health care organization that conducts...
This is a federal contract award issued by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization in Marshfield, Wisconsin. The $241,487 firm fixed-price contract is for "ENHANCING THE SERUM REPOSITORY FOR LYME DISEASE" and has a period of performance through December 31, 2023. Marshfield Clinic, Inc. is a subsidiary of the parent organization Marshfield Clinic Health System, Inc., which has a significant history of federal...
This $19,981,955 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic Health System, Inc., a non-profit healthcare organization, to provide centralized molecular testing and analysis services to support the CDC's monitoring efforts for SARS-CoV-2 and influenza viruses. The contract includes assessing the effectiveness of COVID-19 vaccines. This award is not associated with a set-aside program. In addition to serving as a prime...
Marshfield Clinic has been awarded a definitive cost-no-fee contract valued at $22.6 million by the Centers for Disease Control and Prevention to provide centralized molecular assessment of SARS and influenza virus infections for multi-site prospective cohorts. The contract will support the CDC's efforts to respond to the Coronavirus COVID-19 pandemic through prospective cohort studies and molecular testing of samples from infected individuals. Marshfield Clinic will serve as the prime...
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization. The contract, titled "MMR3 LONG TERM FOLLOW UP STUDY", has a ceiling value of $280,051 and an ultimate completion date of June 4, 2022. The contract does not have a set-aside designation. Marshfield Clinic, Inc. is the prime contractor, and there are no subcontractors mentioned. This contract is part of the Vaccine...
This is a federal contract awarded to Marshfield Clinic, Inc., a non-profit healthcare organization, by an unnamed U.S. government agency. The contract, which is a Definitive Contract with a Cost No Fee pricing type, has a potential value of $61,350,749.00 and was awarded on June 25, 1999 with a completion date of January 31, 2007. The contract does not have a set-aside designation. Marshfield Clinic, which has a history of partnering with government agencies like the Centers for Disease Control...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc. for a follow-up study to assess immunogenicity associated with a third dose of the measles-mumps-rubella (MMR) vaccine. The contract has a total potential value of $99,565.00 and a completion date of July 31, 2019. Marshfield Clinic is the only source with access to the cohort of 665 subjects who are clients of the clinic, and the contract is sole-sourced under the...
This federal contract award is for a project under the Vaccine Safety Datalink (VSD) between the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) and Marshfield Clinic, Inc., a non-profit healthcare organization. The $2,925,737.80 delivery order contract is for the provision of critical functions related to the VSD project, which supports vaccine safety monitoring and research. As the prime contractor, Marshfield Clinic will provide ongoing vaccine...

This federal contract award to Marshfield Clinic, Inc., a non-profit healthcare organization, is for the SERUM REPOSITORY project. The contract, awarded by the Centers for Disease Control and Prevention (CDC), has a ceiling value of $1,230,268.00 and is a Definitive Contract with a Firm Fixed Price pricing type. The ultimate completion date is September 24, 2028. This contract is not a set-aside award.

Marshfield Clinic, Inc. is the prime contractor, and its parent organization is Marshfield Clinic Health System, Inc., another non-profit healthcare entity. The contract involves providing critical scientific research, data analysis, vaccine safety monitoring, epidemiological studies, and specialized healthcare services to the CDC. This work is part of Marshfield Clinic's broader federal contract and grant portfolio, which demonstrates its extensive capabilities in medical research, clinical studies, and public health initiatives, primarily focused on areas such as vaccine safety, disease surveillance, and COVID-19 research.

Generated 6/18/25, 11:20 AM